Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia · Delayed Price · Currency is SAR
138.40
-0.80 (-0.57%)
Mar 24, 2026, 12:35 PM AST
Revenue by Segment
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 216.77M | 179.07M | 144.09M | 119.30M | 72.22M | | | |
Consumer Health Products Growth | 21.05% | 24.28% | 20.78% | 65.18% | -2.60% | | | |
| 1.28B | 1.14B | 956.73M | 797.38M | 663.46M | | | |
Pharmaceutical Products Growth | 12.68% | 19.09% | 19.98% | 20.18% | -9.26% | | | |
| 1.50B | 1.32B | 1.10B | 916.67M | 735.68M | | | |
| 13.82% | 19.77% | 20.09% | 24.60% | -8.65% | | | |
Revenue by Geography
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 988.67M | 857.67M | 720.59M | 587.13M | 466.10M | | | |
Kingdom of Saudi Arabia Growth | 15.27% | 19.02% | 22.73% | 25.97% | -13.47% | | | |
| 200.60M | 181.68M | 139.93M | 108.70M | 73.27M | | | |
| 10.41% | 29.84% | 28.73% | 48.35% | -21.18% | | | |
| 130.85M | 116.19M | 105.14M | 91.15M | 64.58M | | | |
| 12.61% | 10.51% | 15.34% | 41.14% | 25.42% | | | |
| 74.27M | 70.60M | 59.24M | 64.17M | 67.04M | | | |
| 5.20% | 19.18% | -7.69% | -4.28% | 13.55% | | | |
North Africa and Other Export Markets | 106.24M | 92.34M | 75.93M | 65.52M | 64.69M | | | |
North Africa and Other Export Markets Growth | 15.06% | 21.61% | 15.89% | 1.28% | 2.44% | | | |
| 1.50B | 1.32B | 1.10B | 916.67M | 735.68M | | | |
| 13.82% | 19.77% | 20.09% | 24.60% | -8.65% | | | |
Source: S&P Global Market Intelligence.